114
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Small Cell Lung Cancer

ORCID Icon, , , & ORCID Icon
Pages 3255-3262 | Published online: 01 Dec 2021

References

  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128.
  • Mouronte-Roibas C, Leiro-Fernandez V, Fernandez-Villar A, Botana-Rial M, Ramos-Hernandez C, Ruano-Ravina A. COPD, emphysema and the onset of lung cancer. A systematic review. Cancer Lett. 2016;382(2):240–244. doi:10.1016/j.canlet.2016.09.002
  • Ho CH, Chen YC, Wang JJ, Liao KM. Incidence and relative risk for developing cancer among patients with COPD: a nationwide cohort study in Taiwan. BMJ Open. 2017;7(3):e013195. doi:10.1136/bmjopen-2016-013195
  • Qu P, Roberts J, Li Y, et al. Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease. Lung Cancer. 2009;63(3):341–347. doi:10.1016/j.lungcan.2008.05.025
  • Balata H, Harvey J, Barber PV, et al. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD. Thorax. 2020;75(8):655–660. doi:10.1136/thoraxjnl-2019-213584
  • Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–386. doi:10.1183/09031936.00144208
  • Lee SJ, Lee J, Park YS, et al. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer. J Thorac Oncol. 2014;9(6):812–817. doi:10.1097/JTO.0000000000000158
  • Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer. 2003;103(6):792–802. doi:10.1002/ijc.10882
  • Gao YH, Guan WJ, Liu Q, et al. Impact of COPD and emphysema on survival of patients with lung cancer: a meta-analysis of observational studies. Respirology. 2016;21(2):269–279. doi:10.1111/resp.12661
  • Tan LE, Razak AM, Lim CS. Association of chronic obstructive pulmonary disease and postresection lung cancer survival: a systematic review and meta-analysis. J Investig Med. 2017;65(2):342–352. doi:10.1136/jim-2016-000059
  • Wu K, Wang J, Zhao L, Wang P, Duan Q. The prognosis of non-small cell lung cancer combined with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Clin Respir J. 2020;14(4):389–396. doi:10.1111/crj.13144
  • Hsu YC. Analyzing Taiwan's National Health Insurance Research Database to explicate the allocation of health-care resources. Advances in Digestive Medicine. 2015;2:41-43. doi:10.1016/j.aidm.2015.04.001.
  • Sekine Y, Suzuki H, Yamada Y, Koh E, Yoshino I. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection. Thorac Cardiovasc Surg. 2013;61(2):124–130. doi:10.1055/s-0032-1304543
  • Aarts MJ, Aerts JG, van den Borne BE, Biesma B, Lemmens VE, Kloover JS. Comorbidity in patients with small-cell lung cancer: trends and prognostic impact. Clin Lung Cancer. 2015;16(4):282–291. doi:10.1016/j.cllc.2014.12.003
  • Ju S, Lee HR, Kim JY, et al. Impact of coexistent chronic obstructive pulmonary disease on the survival of patients with small cell lung cancer receiving chemotherapy. Thorac Cancer. 2018;9(10):1271–1278. doi:10.1111/1759-7714.12832
  • Ludbrook JJ, Truong PT, MacNeil MV, et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys. 2003;55(5):1321–1330. doi:10.1016/S0360-3016(02)04576-5
  • Hatlen P, Gronberg BH, Langhammer A, Carlsen SM, Amundsen T. Prolonged survival in patients with lung cancer with diabetes mellitus. J Thorac Oncol. 2011;6(11):1810–1817. doi:10.1097/JTO.0b013e31822a75be
  • Wang G, Li X, Xiong R, Wu H, Xu M, Xie M. Long-term survival analysis of patients with non-small cell lung cancer complicated with type 2 diabetes mellitus. Thorac Cancer. 2020;11(5):1309–1318. doi:10.1111/1759-7714.13398
  • Inal A, Kaplan MA, Kucukoner M, Urakci Z, Kilinc F, Isikdogan A. Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer? Rev Port Pneumol. 2014;20(2):62–68. doi:10.1016/j.rppneu.2013.09.001
  • Kurishima K, Watanabe H, Ishikawa H, Satoh H, Hizawa N. Survival of patients with lung cancer and diabetes mellitus. Mol Clin Oncol. 2017;6(6):907–910. doi:10.3892/mco.2017.1224
  • Inal A, Kaplan MA, Kucukoner M, et al. Is diabetes mellitus a prognostic factor for survival in patients with small cell lung cancer? APJCP. 2012;13(4):1491–1494. doi:10.7314/APJCP.2012.13.4.1491